< Back to Images

PART 16: Endocrinology and Metabolism
SECTION 1   Endocrinology

342 Disorders of the Adrenal Cortex
Wiebke Arlt

Figure 342-1  Adrenal steroidogenesis. CYP11A1, side chain cleavage enzyme; CYP17A1, 17α-hydroxylase/17,20 lyase; POR, P450 oxidoreductase; ADX, adrenodoxin; HSD3B2, 3β-hydroxysteroid dehydrogenase type 2; CYP21A2, 21-hydroxylase; CYP11B1, 11β-hydroxylase; CYP11B2, aldosterone synthase;...
view large
Figure 342-2  Regulation of the hypothalamic-pituitary-adrenal (HPA) axis. CRH, corticotropin-releasing hormone; ACTH, adrenocorticotropic hormone.
view large
Figure 342-3  Physiologic cortisol circadian rhythm.

Circulating cortisol concentrations drop under the rhythm-adjusted mean (MESOR) in the early evening hours, with nadir levels around midnight and a rise in the early morning hours; peak levels are observed ∼8:30 a.m. (acrophase).

view large
Figure 342-4  Regulation of the renin-angiotensin-aldosterone (RAA) system.
view large
Figure 342-5  ACTH effects on adrenal steroidogenesis. ACTH, adrenocorticotropic hormone; ATP, adenosine triphosphate; CRE, cAMP response element; CREB, cAMP response element binding; MRAP, MC2R-accessory protein; StAR, steroidogenic acute regulatory [protein].
view large
Figure 342-6  Prereceptor activation of cortisol and glucocorticoid receptor (GR) action. GRE, glucocorticoid response elements; HSP, heat shock proteins; NADPH, nicotinamide adenine dinucleotide phosphate (reduced form).
view large
Figure 342-7  Prereceptor inactivation of cortisol and mineralocorticoid receptor action.
view large
Figure 342-8  Clinical features of Cushing's syndrome. A. Note central obesity and broad, purple stretch marks (B. close-up). C. Note thin and brittle skin in an elderly patient with Cushing's.
view large
Figure 342-9  Management of the patient with suspected Cushing's syndrome. CHR, corticotropin-releasing hormone; DEX, dexamethasone.
view large
Figure 342-10  Adrenal imaging in Cushing's syndrome. A. Adrenal CT showing normal bilateral adrenal morphology (arrows). B. MRI showing bilateral adrenal hyperplasia due to excess ACTH stimulation in Cushing's disease.
view large
Figure 342-11  Management of patients with suspected mineralocorticoid excess. Perform adrenal tumor workup (see Fig. 342-12). GC/MS, gaschromatography/mass spectometry.
view large
Figure 342-12  Management of the patient with an incidentally discovered adrenal mass. F/U, follow-up.
view large
Figure 342-13  Imaging in adrenocortical carcinoma. MRI scan with A. frontal and B. lateral views of a left adrenocortical carcinoma that was detected incidentally. CT scan with C. coronal and
view large
Figure 342-14  Clinical features of Addison's disease. Note the hyperpigmentation in areas of increased friction including (A) palmar creases, (B) dorsal foot, (C) nipples and axillary region, and (
view large
Figure 342-15  Management of the patient with suspected adrenal insufficiency. PRA, plasma renin activity.
view large
Figure 342-16  Imaging in congenital adrenal hyperplasia (CAH). Adrenal CT scans showing homogenous bilateral hyperplasia in a young patient with classic CAH A and macronodular bilateral hyperplasia B in a middle-aged classic CAH patient with...
view large